Genetic, Epigenetic, and Signaling Pathways in the Ovarian and Uterine Pathogenesis

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Reproductive Biology".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 427

Special Issue Editors

Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA
Interests: uterine fibroid; uterine sarcoma; epigenetics; developmental reprogramming; signaling pathway; hormones and endocrine function; omics

E-Mail Website
Guest Editor
Department of Biology, Yazd University, Yazd 8915818411, Iran
Interests: female infertility; gynaecological cancer; targeted drug delivery; extracellular vesicles; biomarker discovery; epigenomics and epitranscriptomics

Special Issue Information

Dear Colleagues,

The ovaries and uterus are part of the female reproductive system. The ovaries produce oocytes and female hormones, and the uterus is the place where a baby grows when a woman is pregnant. Both organs are connected by uterine tubes. Ovary and uterus diseases affect women’s life with significant morbidity and represent significant societal health and financial burden. The etiologies are complex and generally not fully understood. Therefore, better characterization and understanding of the cellular and molecular events driving these disorders are critical to preventing and treating the diseases.

The emerging therapeutic agents targeting aberrant genomes, epigenome, and biological pathways provide significant clinical potential. Therefore, a deep dive into the mechanism underlying the pathogenesis of ovarian and uterine diseases is needed to identify new potential target genes and pathways to enhance our understanding and improve the development of therapeutic agents for reproductive diseases.

This Special Issue aims to provide an overview of the current developments in ovarian and uterine diseases. We welcome submissions of original research and review articles that relate to understanding the genome, epigenome, and pathways in ovarian and uterine disorders. In addition, submissions of topics in the field of basic and translational research, diagnostic, and treatment applications are welcome.

Dr. Qiwei Yang
Dr. Ali Falahati
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • uterine disorders
  • ovarian diseases
  • epigenetic
  • signal pathways
  • immune response
  • extracellular vesicles
  • microenvironment
  • omics study
  • screening models
  • epitranscriptomics

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop